These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32088826)

  • 1. Introduction of a multicenter online database for non-metastatic breast cancer in China.
    Yang Y; Liu J; Peng M; Su F; Xie X; Liu Z; Wu J; Wei W; Zhou D; Li W; Zhang A; Su G; Yang W; Chen J; Ma D; Cai Y; Chen K; Zhu L; Liu Q; Song E
    Sci China Life Sci; 2020 Sep; 63(9):1417-1420. PubMed ID: 32088826
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database.
    Hwang KT; Kim J; Jung J; Chang JH; Chai YJ; Oh SW; Oh S; Kim YA; Park SB; Hwang KR
    Clin Cancer Res; 2019 Mar; 25(6):1970-1979. PubMed ID: 30559169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive lobular breast cancer: does grade matter?
    Margenthaler JA
    J Surg Res; 2011 Jul; 169(1):16-8. PubMed ID: 20850783
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study.
    Overcast WB; Zhang J; Zynger DL; Tozbikian GH
    Virchows Arch; 2016 Aug; 469(2):203-12. PubMed ID: 27220765
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis.
    Ding S; Wu J; Lin C; Andriani L; Goh C; Chen W; Li Y; Shen K; Zhu L
    Oncologist; 2019 Nov; 24(11):e1014-e1023. PubMed ID: 31019021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
    Lin H; Wu Y; Liang G; Chen L
    PLoS One; 2020; 15(11):e0242155. PubMed ID: 33170907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ER
    Arciero CA; Guo Y; Jiang R; Behera M; O'Regan R; Peng L; Li X
    Clin Breast Cancer; 2019 Aug; 19(4):236-245. PubMed ID: 30846407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.
    Zell JA; Tsang WY; Taylor TH; Mehta RS; Anton-Culver H
    Breast Cancer Res; 2009; 11(1):R9. PubMed ID: 19228416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series.
    McCormack VA; Joffe M; van den Berg E; Broeze N; Silva Idos S; Romieu I; Jacobson JS; Neugut AI; Schüz J; Cubasch H
    Breast Cancer Res; 2013; 15(5):R84. PubMed ID: 24041225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.
    Tan Y; Li X; Chen H; Hu Y; Jiang M; Fu J; Yuan Y; Ding K
    Oncotarget; 2016 Oct; 7(43):70991-71000. PubMed ID: 27542240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of Chinese multicenter breast cancer database and SEER database.
    Niu Y; Zhang F; Chen D; Ye G; Li Y; Zha Y; Chen W; Liu D; Liao X; Huang Q; Tang W; Cai G; Guo R; Li H; Tang S
    Sci Rep; 2022 Jun; 12(1):10395. PubMed ID: 35729333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study.
    Yu P; Tang H; Zou Y; Liu P; Tian W; Zhang K; Xie X; Ye F
    Cancer Control; 2020; 27(1):1073274820976667. PubMed ID: 33356518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of primary breast salivary gland-type carcinoma: a propensity score-matching analysis with invasive carcinoma of no special type based on the SEER database for years 2010-2020.
    Ch'ng ES
    Breast Cancer; 2024 May; 31(3):496-506. PubMed ID: 38546966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?
    Iorfida M; Dellapasqua S; Bagnardi V; Cardillo A; Rotmensz N; Mastropasqua MG; Bottiglieri L; Goldhirsch A; Viale G; Colleoni M
    Ann Oncol; 2012 May; 23(5):1371-1372. PubMed ID: 22412042
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of HER2 protein examination in ductal carcinoma in situ.
    Horimoto Y; Tokuda E; Arakawa A; Kosaka T; Saito M; Kasumi F
    J Surg Res; 2011 May; 167(2):e205-10. PubMed ID: 20018297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Adjuvant Treatment in Small Node-negative HER2-positive Breast Cancer: Which Subgroup Will Benefit?
    Lin H; Zheng H; Ge C; Wang Q; Tang W; Zhang X; Zhou S; Jin X; Xu X; Du J; Fu J
    Clin Breast Cancer; 2020 Dec; 20(6):503-510. PubMed ID: 32653474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
    Liu YR; Jiang YZ; Yu KD; Shao ZM
    Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between prolonged metastatic free interval and recurrent metastatic breast cancer survival: findings from the SEER database.
    Chang E; Mougalian SS; Adelson KB; Young MR; Yu JB
    Breast Cancer Res Treat; 2019 Jan; 173(1):209-216. PubMed ID: 30242577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis.
    Han Y; Wang J; Xu B
    Breast; 2020 Dec; 54():114-120. PubMed ID: 32979771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.